Effect of teneligliptin on endothelial dysfunction induced by postprandial hypelipidemia

Trial Profile

Effect of teneligliptin on endothelial dysfunction induced by postprandial hypelipidemia

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 May 2016

At a glance

  • Drugs Teneligliptin (Primary)
  • Indications Metabolic syndrome
  • Focus Pharmacodynamics
  • Most Recent Events

    • 15 Jan 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 21 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top